news and Insights

From Organoid to Clinic: What Signet Therapeutics’ SIGX1094 Reveals About the Future of Drug Development

9. February 2026

FDA’s Animal Testing Phase-Out: A Regulatory Shift with Immediate Implications for Organoid Science